SARS-CoV-2 infection among healthcare workers whom already received booster vaccination during epidemic outbreak of omicron variant in Taiwan

被引:4
|
作者
Sheng, Wang-Huei [1 ,2 ,9 ]
Chang, Hao-Chun [3 ]
Chang, Sui-Yuan [4 ,5 ]
Hsieh, Ming-Ju [6 ,7 ]
Chen, Yu-Cheng [4 ]
Wu, Yu-Yun [6 ]
Pan, Sung-Ching [1 ,8 ]
Wang, Jann-Tay [1 ,2 ]
Chen, Yee -Chun [1 ,8 ]
机构
[1] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan
[2] Natl Taiwan Univ, Sch Med, Coll Med, Taipei, Taiwan
[3] Natl Taiwan Univ Hosp, Dept Internal Med, Hsin Chu Branch, Hsinchu, Taiwan
[4] Natl Taiwan Univ, Dept Clin Lab Sci & Med Biotechnol, Coll Med, Taipei, Taiwan
[5] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan
[6] Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei, Taiwan
[7] Natl Taiwan Univ Hosp, Occupat Safety & Hlth Off, Taipei, Taiwan
[8] Natl Taiwan Univ Hosp, Infect Control Ctr, Taipei, Taiwan
[9] Natl Taiwan Univ Hosp, Dept Internal Med, 7 Chung Shan South Rd, Taipei 10002, Taiwan
关键词
Coronavirus disease 2019 (COVID-19); Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2); Anti-SARS-CoV-2 nucleocapsid protein antibody; Risk factors; Healthcare workers; COVID-19;
D O I
10.1016/j.jfma.2022.12.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/Purpose: Healthcare workers (HCWs) are at risk of severe acute respi-ratory syndrome coronavirus 2 (SARS-CoV-2) infection due to occupational exposure. We aim to investigate the prevalence and risk factors of SARS-CoV-2 infection among HCWs during epidemic outbreak of omicron variant in Taiwan.Methods: Sequential reserved serum samples collected from our previous study during December 2021 and July 2022 were tested for antibodies against SARS-CoV-2 nucleocapsid pro-tein (NP). Diagnosis of SARS-CoV-2 infection was defined as positive either of anti-SARS-CoV-2 nucleoprotein, rapid antigen test or polymerase chain reaction. Retrospective chart review and a questionnaire were used to access the symptoms and risk factors for SARS-CoV-2 infection. Results: Totally 300 participants (69.3% female) with a median age of 37.9 years were enrolled. A significant increase incidence of SARS-CoV-2 infection was found before and during community outbreak (11.91 versus 230.93 per 100,000 person-days, P < 0.001), which was a trend paralleling that observed in the general population. For 61 SARS-CoV-2 infected partic-ipants, nine (14.8%) were asymptomatic. Multivariate analysis revealed recent contact with a SARS-CoV-2 infected household (odds ratio [OR], 7.01; 95% confidence interval [95% CI], 3.70 -13.30; P < 0.001) and co-existed underlying autoimmune diseases (OR, 4.46; 95% CI, 1.28 -15.51; P Z 0.019) were significant risk factors associated with acquisition of SARS-CoV-2 infection among HCWs.Conclusion: Community factors, such as closely contact with SARS-CoV-2 infected individuals and underlying immune suppression status, were significant factors for acquisition of SARS-CoV-2 infection among HCWs. We suggest the application of appropriate infection control mea-sures for HCWs should be maintained to reduce risk of SARS-CoV-2 infection.Copyright 2022, Formosan Medical Association. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:376 / 383
页数:8
相关论文
共 50 条
  • [1] Second SARS-CoV-2 Booster Vaccination Significantly Reduces Haemodialysis Patients' Susceptibility to Infection With Omicron Variant
    Wall, Nadezhda
    Banham, Gemma D.
    Casey, Anna L.
    Richter, Alex
    Cunningham, Adam F.
    Harper, Lorraine
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 314 - 314
  • [2] Co-Occurrence of SARS-CoV-2 Infection and Inactivated SARS-CoV-2 Vaccination among Healthcare Workers
    Cucunawangsih, Cucunawangsih
    Wijaya, Ratna Sari
    Lugito, Nata Pratama Hardjo
    Suriapranata, Ivet
    CASE REPORTS IN INFECTIOUS DISEASES, 2021, 2021
  • [3] Effectiveness of Bivalent Omicron-Containing Booster Vaccines against SARS-CoV-2 Omicron Variant among Individuals with and without Prior SARS-CoV-2 Infection
    Widyasari, Kristin
    Jang, Jieun
    Kang, Taejoon
    Kim, Sunjoo
    VIRUSES-BASEL, 2023, 15 (08):
  • [4] Impact of COVID-19 Vaccination on Healthcare Worker Infection Rate and Outcome during SARS-CoV-2 Omicron Variant Outbreak in Hong Kong
    Zee, Sze-Tsing
    Kwok, Lam-Fung
    Kee, Ka-Man
    Fung, Ling-Hiu
    Luk, Wing-Pan
    Chan, Tsun-Leung
    Leung, Chin-Pang
    Yu, Pik-Wa
    Hung, Jhan
    SzeTo, Kit-Ying
    Chan, Wai-Leng
    Tang, Siu-Fai
    Lin, Wai-Chi
    Ma, Shiu-Kwan
    Lee, Koon-Hung
    Lau, Chor-Chiu
    Yung, Wai-Hung
    VACCINES, 2022, 10 (08)
  • [5] Autochthonous Outbreak of SARS-CoV-2 Omicron Variant in Booster-Vaccinated (3 Doses) Healthcare Workers in Southern Italy: Just the Tip of the Iceberg?
    Loconsole, Daniela
    Bisceglia, Lucia
    Centrone, Francesca
    Sallustio, Anna
    Accogli, Marisa
    Dalfino, Lidia
    Brienza, Nicola
    Chironna, Maria
    VACCINES, 2022, 10 (02)
  • [6] Reduced sensitivity of SARS-CoV-2 Omicron variant to antibody neutralization elicited by booster vaccination
    Xiaoqi Yu
    Dong Wei
    Wenxin Xu
    Yulong Li
    Xinxin Li
    Xinxin Zhang
    Jieming Qu
    Zhitao Yang
    Erzhen Chen
    Cell Discovery, 8
  • [7] mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant
    Nanishi, Etsuro
    McGrath, Marisa E.
    O'Meara, Timothy R.
    Barman, Soumik
    Yu, Jingyou
    Wan, Huahua
    Dillen, Carly A.
    Menon, Manisha
    Seo, Hyuk-Soo
    Song, Kijun
    Xu, Andrew Z.
    Sebastian, Luke
    Brook, Byron
    Bosco, Anna-Nicole
    Borriello, Francesco
    Ernst, Robert K.
    Barouch, Dan H.
    Dhe-Paganon, Sirano
    Levy, Ofer
    Frieman, Matthew B.
    Dowling, David J.
    COMMUNICATIONS BIOLOGY, 2022, 5 (01)
  • [8] mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant
    Etsuro Nanishi
    Marisa E. McGrath
    Timothy R. O’Meara
    Soumik Barman
    Jingyou Yu
    Huahua Wan
    Carly A. Dillen
    Manisha Menon
    Hyuk-Soo Seo
    Kijun Song
    Andrew Z. Xu
    Luke Sebastian
    Byron Brook
    Anna-Nicole Bosco
    Francesco Borriello
    Robert K. Ernst
    Dan H. Barouch
    Sirano Dhe-Paganon
    Ofer Levy
    Matthew B. Frieman
    David J. Dowling
    Communications Biology, 5
  • [9] Reduced sensitivity of SARS-CoV-2 Omicron variant to antibody neutralization elicited by booster vaccination
    Yu, Xiaoqi
    Wei, Dong
    Xu, Wenxin
    Li, Yulong
    Li, Xinxin
    Zhang, Xinxin
    Qu, Jieming
    Yang, Zhitao
    Chen, Erzhen
    CELL DISCOVERY, 2022, 8 (01)
  • [10] SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination
    Qi, Xian
    Qiu, Haibo
    Bao, Changjun
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (11):